Division of Nephrology, Seattle Children's Hospital Research Institute, Department of Pediatrics, University of Washington, Seattle, WA 98101, USA.
Lab Invest. 2011 Jan;91(1):106-23. doi: 10.1038/labinvest.2010.135. Epub 2010 Jul 26.
The nicotinic acetylcholine receptor α1 (nAChRα1) was investigated as a potential proinflammatory molecule in the kidney, given a recent report that it is an alternative urokinase plasminogen activator (uPA) receptor, in addition to the classical receptor uPAR. Two animal models and in vitro monocyte studies were involved: (1) In an ApoE(-/-) mouse model of chronic kidney disease, glomerular-resident cells and monocytes/macrophages were identified as the primary cell types that express nAChRα1 during hypercholesterolemia/uninephrectomy-induced nephropathy. Silencing of the nAChRα1 gene for 4 months (6 months on Western diet) prevented the increases in renal monocyte chemoattractant protein-1 and osteopontin expression levels and F4/80+ macrophage infiltration compared with the nonsilenced mice. These changes were associated with significantly reduced transforming growth factor-β1 mRNA (50% decrease) and α smooth muscle actin-positive (αSMA+) myofibroblasts (90% decrease), better glomerular and tubular basement membranes (GBM/TBM) preservation (threefold less disintegration), and better renal function preservation (serum creatinine 40% lower) in the nAChRα1-silenced mice. The nAChRα1 silencing was also associated with significantly reduced renal tissue calcium deposition (78% decrease) and calpain-1 (but not calpain-2) activation (70% decrease). (2) The nAChRα1 was expressed in vitro by mouse monocyte cell line WEHI-274.1. The silencing of nAChRα1 significantly reduced both calpain-1 and -2 activities, and reduced the degradation of the calpain substrate talin. (3) To further explore the role of calpain-1 activity in hypercholesterolemic nephropathy, disease severities were compared in CAST(-/-)ApoE(-/-) (calpain overactive) mice and ApoE(-/-) mice fed with Western diet for 10 months (n=12). Macrophages were the main cell type of renal calpain-1 production in the model. The number of renal F4/80+ macrophages was 10-fold higher in the CAST(-/-)ApoE(-/-) mice (P<0.05), and was associated with a significantly higher level of αSMA+ cells, increased GBM/TBM destruction, and higher serum creatinine levels. Our studies suggest that the receptor nAChRα1 is an important regulator of calpain-1 activation and inflammation in the chronic hypercholesterolemic nephropathy. This new proinflammatory pathway may also be relevant to other disorders beyond hyperlipidemic nephropathy.
烟碱型乙酰胆碱受体α1(nAChRα1)作为肾脏中的潜在促炎分子受到了关注,因为最近有报道称它是尿激酶纤溶酶原激活物(uPA)的替代受体,除了经典受体 uPAR 之外。本研究涉及两个动物模型和体外单核细胞研究:(1)在载脂蛋白 E(-/-)小鼠慢性肾脏病模型中,肾小球固有细胞和单核细胞/巨噬细胞被鉴定为在高胆固醇血症/单侧肾切除诱导的肾病期间表达 nAChRα1 的主要细胞类型。用 nAChRα1 基因沉默 4 个月(在西方饮食上 6 个月)可防止肾单核细胞趋化蛋白-1 和骨桥蛋白表达水平以及 F4/80+巨噬细胞浸润的增加与未沉默的小鼠相比。这些变化与转化生长因子-β1 mRNA 的显著减少(减少 50%)和α平滑肌肌动蛋白阳性(αSMA+)肌成纤维细胞(减少 90%)、肾小球和肾小管基底膜(GBM/TBM)保存的改善(减少三分之一的崩解)以及 nAChRα1 沉默小鼠的肾功能保存(血清肌酐降低 40%)有关。nAChRα1 沉默还与肾组织钙沉积减少(减少 78%)和钙蛋白酶-1(而不是钙蛋白酶-2)活性降低(减少 70%)有关。(2)在体外,烟碱型乙酰胆碱受体α1 通过鼠单核细胞系 WEHI-274.1 表达。nAChRα1 的沉默显著降低了钙蛋白酶-1 和 -2 的活性,并减少了钙蛋白酶底物桩蛋白的降解。(3)为了进一步探讨钙蛋白酶-1 活性在高胆固醇血症肾病中的作用,比较了 10 个月饲喂西方饮食的 CAST(-/-)ApoE(-/-)(钙蛋白酶过度活跃)小鼠和 ApoE(-/-)小鼠的疾病严重程度(n=12)。在该模型中,巨噬细胞是肾脏钙蛋白酶-1 产生的主要细胞类型。在 CAST(-/-)ApoE(-/-)小鼠中,肾脏 F4/80+巨噬细胞的数量增加了 10 倍(P<0.05),与更高水平的αSMA+细胞、GBM/TBM 破坏增加和血清肌酐水平升高有关。我们的研究表明,受体 nAChRα1 是慢性高胆固醇血症性肾病中钙蛋白酶-1 激活和炎症的重要调节剂。这种新的促炎途径也可能与除高脂血症性肾病以外的其他疾病有关。